Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 4;9(6):e98593.
doi: 10.1371/journal.pone.0098593. eCollection 2014.

Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract

Elisabeth Kleppa  1 , Veron Ramsuran  2 , Siphosenkosi Zulu  3 , Gunn Hege Karlsen  4 , Alfred Bere  5 , Jo-Ann S Passmore  6 , Patricia Ndhlovu  7 , Kristine Lillebø  1 , Sigve D Holmen  1 , Mathias Onsrud  8 , Svein Gunnar Gundersen  9 , Myra Taylor  3 , Eyrun F Kjetland  10 , Thumbi Ndung'u  2
Affiliations

Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract

Elisabeth Kleppa et al. PLoS One. .

Abstract

Background: Schistosoma haematobium is a waterborne parasite that may cause female genital schistosomiasis (FGS), characterized by genital mucosal lesions. There is clinical and epidemiological evidence for a relationship between FGS and HIV. We investigated the impact of FGS on HIV target cell density and expression of the HIV co-receptor CCR5 in blood and cervical cytobrush samples. Furthermore we evaluated the effect of anti-schistosomal treatment on these cell populations.

Design: The study followed a case-control design with post treatment follow-up, nested in an on-going field study on FGS.

Methods: Blood and cervical cytobrush samples were collected from FGS negative and positive women for flow cytometry analyses. Urine samples were investigated for schistosome ova by microscopy and polymerase chain reaction (PCR).

Results: FGS was associated with a higher frequency of CD14+ cells (monocytes) in blood (11.5% in FGS+ vs. 2.2% in FGS-, p = 0.042). Frequencies of CD4+ cells expressing CCR5 were higher in blood samples from FGS+ than from FGS- women (4.7% vs. 1.5%, p = 0.018). The CD14+ cell population decreased significantly in both compartments after anti-schistosomal treatment (p = 0.043). Although the frequency of CD4+ cells did not change after treatment, frequencies of CCR5 expression by CD4+ cells decreased significantly in both compartments (from 3.4% to 0.5% in blood, p = 0.036; and from 42.4% to 5.6% in genital samples, p = 0.025).

Conclusions: The results support the hypothesis that FGS may increase the risk of HIV acquisition, not only through damage of the mucosal epithelial barrier, but also by affecting HIV target cell populations, and that anti-schistosomal treatment can modify this.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Colposcopic image of cervix with female genital schistosomiasis.
The image shows sandy patches appearing as grains (arrows point to some examples) and contact bleeding.
Figure 2
Figure 2. Flowchart.
Flowchart showing the inclusion of study participants (FGS =  female genital schistosomiasis, CVL =  cervicovaginal lavage).
Figure 3
Figure 3. Gating strategy.
Figures showing the gating strategy for A) CD3+ B) CD3−CD56+ C) CD3+CD4+ and CD3+CD8+ and D) CD3−CD56−CD14+.
Figure 4
Figure 4. Comparison of FGS+ and FGS−.
Figures comparing the FGS positive (genital sandy patches) and negative (no genital sandy patches, negative Schistosoma PCR in cervicovaginal lavage/urine and negative urine microscopy for ova). Figures show blood (A–B) and cervical samples (C–D).
Figure 5
Figure 5. Effect of praziquantel treatment.
Figures comparing FGS positive individuals in blood (A–B) and cervical samples (C–D) before and after praziquantel (40 mg/kg) treatment.
See this image and copyright information in PMC

References

    1. Shacklett BL (2010) Immune responses to HIV and SIV in mucosal tissues: “location, location, location”. Curr Opin HIV AIDS 5: 128–134 doi:10.1097/COH.0b013e328335c178 - DOI - PMC - PubMed
    1. UNAIDS report on the global AIDS epidemic 2010 (2010).
    1. Greenhead P, Hayes P, Watts PS, Laing KG, Griffin GE, et al. (2000) Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 74: 5577–5586. - PMC - PubMed
    1. Kaul R, Pettengell C, Sheth PM, Sunderji S, Biringer A, et al. (2008) The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol 77: 32–40 doi:10.1016/j.jri.2007.02.002 - DOI - PubMed
    1. Iqbal SM, Kaul R (2008) Mucosal innate immunity as a determinant of HIV susceptibility. Am J Reprod Immunol 59: 44–54 doi:10.1111/j.1600-0897.2007.00563.x - DOI - PubMed

Publication types

MeSH terms